Effect of an Atlantic Diet on Anthropometric Indices and Serum Lipid Profile (GALIAT)
Primary Purpose
Cardiovascular Disease, Adiposity, Hypercholesterolemia
Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Diet
Sponsored by
About this trial
This is an interventional treatment trial for Cardiovascular Disease
Eligibility Criteria
A random sample of the population 18 years and older was drawn from the National Health System Register in order to select the index subjects.These individuals (index subjects) and all family members sharing the same house were invited to participate in the study.
Inclusion Criteria:
For the index subject:
- Female or male.
- 18 years and older.
- Living in a family unit with two or more people.
For the other family members:
- Female or male.
- Age between 3 to 85 years.
Exclusion Criteria:
For the index subject:
- Alcoholism
- Lipid treatment
- Pregnant
- Major cardiovascular disease
- Dementia
- Terminal disease
For the other family members:
- Alcoholism
- Pregnant
- Major cardiovascular disease
- Dementia
- Terminal disease
Sites / Locations
- Hospital Clinico Universitario de Santiago
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Diet group
Control
Arm Description
Diet program 1 day a month for 3 months in 120-minute diet sessions + Freely they receive AD food: vegetables, cheese, olive oil, mussels and wine.
No intervention
Outcomes
Primary Outcome Measures
Changes in Total-cholesterol Levels
Change from baseline in total cholesterol:
Enzymatic method using standard kits on an Advia 2400 Clinical Chemistry System (Siemens Healthcare Diagnostics) [Time Frame: 6 months ]
Secondary Outcome Measures
Change From Baseline in Body Weight
Measurements will be made in triplicate and recorded by standard methods using a SECA 813 digital balance with the subjects in underwear and barefoot. Body weight will be measured to the nearest 0.1 kg.
Change From Baseline in Body Mass Index (BMI)
BMI will be calculated as body weight (kg) divided by height (m) squared. The BMI of subjects under 18 years of age will be standardised using World Health Organization (WHO) reference data.
Change From Baseline in Hip/Waist Index
Waist circumference will be measured at the narrowest point between the bottom rib and the top of the iliac crest using a SECA 201 flexible, non-elastic tape.
Hip circumference will be measured at the point of greatest prominence of the gluteal muscles using a SECA 201 flexible, non-elastic tape.
Change From Baseline in Fasting Plasma Glucose
Enzymatic method using standard kits on an Advia 2400 Clinical Chemistry System (Siemens Healthcare Diagnostics)
Full Information
NCT ID
NCT02391701
First Posted
February 11, 2015
Last Updated
April 24, 2020
Sponsor
Hospital Clinico Universitario de Santiago
Collaborators
Ministerio de Economía y Competitividad, Spain
1. Study Identification
Unique Protocol Identification Number
NCT02391701
Brief Title
Effect of an Atlantic Diet on Anthropometric Indices and Serum Lipid Profile
Acronym
GALIAT
Official Title
Effect of an Atlantic Diet on Anthropometric Indices and Serum Lipid Profile in a General Population: a Randomised Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
April 2020
Overall Recruitment Status
Completed
Study Start Date
March 2014 (undefined)
Primary Completion Date
May 2015 (Actual)
Study Completion Date
May 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Hospital Clinico Universitario de Santiago
Collaborators
Ministerio de Economía y Competitividad, Spain
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
BACKGROUND:
The Southern European Atlantic Diet (SEAD) is the traditional diet of Northern Portugal and Galicia, a region in northwest Spain. The SEAD has been associated with a lower risk of non-fatal acute myocardial infarction. Possible mechanisms of this association may be related with a lower concentration of markers of inflammation and with reduced triglycerides, insulin, insulin resistance, and systolic blood pressure.
Aim: To evaluate the effect of an Atlantic Diet on i) lipid profile, ii) markers of inflammation, and iii) anthropometric indices in a population-based study
METHODS:
This is a non-pharmacological clinical trial study which is performed on a family-oriented basis. 250 families (~ 750 children and adults, older than 3 years) were selected to participate in the study and randomized into Atlantic Diet (AD) (n=125 families) and control (n=125 families) groups. The AD groups participate in a diet program 1 day a month for 3 months in 120-minute diet sessions and freely receive AD food, characterized by a high intake of vegetables, cheese, olive oil, mussels and by wine consumption during meals. Control group subjects do not participate in any regular diet activity during this period and did not receive additional food. Exclusion criteria are alcoholism, lipid treatment, dementia, and terminal disease.
Weight, BMI, waist circumference (WC), skin folds, nutrient intake from 3-day recalls, food frequency questionnaire, physical activity, blood pressure, metabolic function (fasting blood glucose, HBA1c, insulin resistance and lipid profile), and inflammation markers (c-reactive protein, interleukin 6 and tumor necrosis factor-alpha) are measured at baseline, 3 and 6 months. Mixed effect models will be performed to assess the significance of changes in the cardiometabolic parameters.
The primary end point is the change in lipid profile compared with baseline and the control group arm at the end of Month 6. The secondary exploratory end points were change in anthropometric indices and inflammation markers at Month 6.
Detailed Description
The intervention period lasted 6 months. At the baseline visit all AD subjects received information on the Atlantic diet and how to follow it; the nutritionists' messages were adapted to the clinical condition of each subject, his/her preferences, needs, beliefs and culture. Special care was taken with patients who were obese, had diabetes or who had high blood cholesterol; conflicts with recommendations made by subjects' own doctors or nutritionists were avoided. All questionnaires (see below) were filled out in the presence of the nutritionists, except for 3-day food records which the subjects handed in completed. The latter were reviewed in the presence of the subjects in order to correct any errors or add missing information. At the 3 and 6 month visits, the nutritionists reminded the subjects about the Atlantic diet and the helped them complete their questionnaires.
Foods were provided to the families of the AD group. Wine was provided only to non-tee-total adults. Food packages were delivered every three weeks to the family home. The food included in the package was calculated for the total number of family members, even if not all were taking part in the study. At delivery, a form was filled in to verify that the previous lot of food had been consumed, and to note any problems.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiovascular Disease, Adiposity, Hypercholesterolemia
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
720 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Diet group
Arm Type
Experimental
Arm Description
Diet program 1 day a month for 3 months in 120-minute diet sessions + Freely they receive AD food: vegetables, cheese, olive oil, mussels and wine.
Arm Title
Control
Arm Type
No Intervention
Arm Description
No intervention
Intervention Type
Behavioral
Intervention Name(s)
Diet
Intervention Description
diet program 1 day a month for 3 months in 120-minute diet sessions + freely receive Atlantic Diet food (vegetables, cheese, olive oil, mussels and wine)
Primary Outcome Measure Information:
Title
Changes in Total-cholesterol Levels
Description
Change from baseline in total cholesterol:
Enzymatic method using standard kits on an Advia 2400 Clinical Chemistry System (Siemens Healthcare Diagnostics) [Time Frame: 6 months ]
Time Frame
baseline and 6 months
Secondary Outcome Measure Information:
Title
Change From Baseline in Body Weight
Description
Measurements will be made in triplicate and recorded by standard methods using a SECA 813 digital balance with the subjects in underwear and barefoot. Body weight will be measured to the nearest 0.1 kg.
Time Frame
Baseline and 6 months
Title
Change From Baseline in Body Mass Index (BMI)
Description
BMI will be calculated as body weight (kg) divided by height (m) squared. The BMI of subjects under 18 years of age will be standardised using World Health Organization (WHO) reference data.
Time Frame
Baseline and 6 months
Title
Change From Baseline in Hip/Waist Index
Description
Waist circumference will be measured at the narrowest point between the bottom rib and the top of the iliac crest using a SECA 201 flexible, non-elastic tape.
Hip circumference will be measured at the point of greatest prominence of the gluteal muscles using a SECA 201 flexible, non-elastic tape.
Time Frame
Baseline and 6 months
Title
Change From Baseline in Fasting Plasma Glucose
Description
Enzymatic method using standard kits on an Advia 2400 Clinical Chemistry System (Siemens Healthcare Diagnostics)
Time Frame
Baseline and 6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
3 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
A random sample of the population 18 years and older was drawn from the National Health System Register in order to select the index subjects.These individuals (index subjects) and all family members sharing the same house were invited to participate in the study.
Inclusion Criteria:
For the index subject:
Female or male.
18 years and older.
Living in a family unit with two or more people.
For the other family members:
Female or male.
Age between 3 to 85 years.
Exclusion Criteria:
For the index subject:
Alcoholism
Lipid treatment
Pregnant
Major cardiovascular disease
Dementia
Terminal disease
For the other family members:
Alcoholism
Pregnant
Major cardiovascular disease
Dementia
Terminal disease
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mar Calvo, PhD
Organizational Affiliation
Servicio Galego de Saude (SERGAS)
Official's Role
Study Chair
Facility Information:
Facility Name
Hospital Clinico Universitario de Santiago
City
Santiago de Compostela
ZIP/Postal Code
15706
Country
Spain
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
27539113
Citation
Calvo-Malvar Mdel M, Leis R, Benitez-Estevez AJ, Sanchez-Castro J, Gude F. A randomised, family-focused dietary intervention to evaluate the Atlantic diet: the GALIAT study protocol. BMC Public Health. 2016 Aug 18;16(1):820. doi: 10.1186/s12889-016-3441-y.
Results Reference
derived
Learn more about this trial
Effect of an Atlantic Diet on Anthropometric Indices and Serum Lipid Profile
We'll reach out to this number within 24 hrs